ASMB
HEALTHCAREAssembly Biosciences Inc
AI Insight
What's Moving ASMB Today?
No stock-specific AI insight has been generated for ASMB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$16.80$39.71
$26.80
Fundamentals
Market Cap$517M
P/E Ratio326.3
EPS$0.08
Dividend Yield—
Dividend / Share—
ROE-5.7%
Profit Margin-9.0%
Debt / Equity—
Trading
Volume254K
Avg Volume (10D)—
Shares Outstanding19.8M
ASMB News
24 articles- Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data AheadMarketbeat·Jun 8, 2026
- Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock unitsStock Titan·Jun 5, 2026
- Assembly Biosciences (ASMB) CMO awarded 14,000-share RSU-based stock grantStock Titan·Jun 5, 2026
- Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline ExpandsMarketbeat·Jun 5, 2026
- Assembly Biosciences Announces Upcoming Investor Conference PresentationsYahoo Finance·May 28, 2026
- Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional SharesYahoo Finance·May 26, 2026
- Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded WarrantsYahoo Finance·May 22, 2026
- Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver DiseasesYahoo Finance·May 22, 2026
- Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA ConferenceMarketbeat·May 14, 2026
- These Analysts Just Made A Huge Downgrade To Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS ForecastsYahoo Finance·May 13, 2026
- Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026Yahoo Finance·May 13, 2026
- Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care ConferenceYahoo Finance·May 11, 2026
- We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash WiselyYahoo Finance·May 11, 2026
- Assembly Biosciences Q1 revenue falls, net loss widensTradingView·May 8, 2026
- Assembly Biosciences: Q1 Earnings SnapshotKVUE·May 7, 2026
- Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 7, 2026
- Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent HighlightsYahoo Finance·May 7, 2026
- Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026Yahoo Finance·Apr 9, 2026
- Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top EstimatesYahoo Finance·Mar 19, 2026
- Assembly Biosciences: Q4 Earnings SnapshotYahoo Finance·Mar 19, 2026
- Assembly Biosciences Reports Year-End 2025 Financial Results and Recent HighlightsYahoo Finance·Mar 19, 2026
- Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 5, 2026
- Personalis (PSNL) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Feb 26, 2026
- Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue EstimatesYahoo Finance·Feb 25, 2026
All 24 articles loaded
Price Data
Open$24.91
Previous Close$25.15
Day High$27.13
Day Low$24.90
52 Week High$39.71
52 Week Low$16.80
52-Week Range
$16.80$39.71
$26.80
Fundamentals
Market Cap$517M
P/E Ratio326.3
EPS$0.08
Dividend Yield—
Dividend / Share—
ROE-5.7%
Profit Margin-9.0%
Debt / Equity—
Trading
Volume254K
Avg Volume (10D)—
Shares Outstanding19.8M
About Assembly Biosciences Inc
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—